Ivermectin and Public Health Cuts: Risks of HHS Restructuring
Restructuring within the U.S. Department of Health and Human Services (HHS) has ignited a nationwide debate about the future of drug oversight, federal healthcare stability, and medical innovation. For years, HHS has served as the backbone of America’s public health response, funding scientific research, supporting hospitals, and ensuring drug safety. Yet recent reforms—marked by staffing … Read more